Evidence map›Paper›PMID 24498325›Full record

ArticlePloS one2014

Bone marrow-specific knock-in of a non-activatable Ikkα kinase mutant influences haematopoiesis but not atherosclerosis in Apoe-deficient mice.

Pathricia V Tilstam, Marion J Gijbels, Mohamed Habbeddine, Céline Cudejko, Yaw Asare, Wendy Theelen, Baixue Zhou, Yvonne Döring, Maik Drechsler, Lukas Pawig and 8 more

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.1field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Anti-inflammatory therapy of atherosclerosis: focusing on IKKβ.Journal of inflammation (London, England) · 2023
    Review
  2. Article
  3. Akt Signaling in Macrophage Polarization, Survival, and Atherosclerosis.International journal of molecular sciences · 2019
    Review
  4. Article
  5. Inhibition of atherogenesis by the COP9 signalosome subunit 5 in vivo.Proceedings of the National Academy of Sciences of the United States of America · 2017
    Article
  6. Macrophage Apoptosis and Efferocytosis in the Pathogenesis of Atherosclerosis.Circulation journal : official journal of the Japanese Circulation Society · 2016
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors at 7 institutions in 3 countries.

Pathricia V TilstamInstitute of Molecular Cardiovascular Research, RWTH Aachen University, Aachen, Germany.
Marion J GijbelsCardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands ; Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Mohamed HabbeddineCentre d'Immunologie de Marseille-Luminy, Aix-Marseille Université, Marseille, France.
Céline CudejkoCentre d'Immunologie de Marseille-Luminy, Aix-Marseille Université, Marseille, France.
Yaw AsareInstitute of Molecular Cardiovascular Research, RWTH Aachen University, Aachen, Germany ; Institute of Biochemistry and Molecular Cell Biology, RWTH Aachen University, Aachen, Germany.
Wendy TheelenInstitute of Molecular Cardiovascular Research, RWTH Aachen University, Aachen, Germany.
Baixue ZhouInstitute of Molecular Cardiovascular Research, RWTH Aachen University, Aachen, Germany.
Yvonne DöringInstitute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany.
Maik DrechslerInstitute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany.
Lukas PawigInstitute of Molecular Cardiovascular Research, RWTH Aachen University, Aachen, Germany.
Sakine SimsekyilmazInstitute of Molecular Cardiovascular Research, RWTH Aachen University, Aachen, Germany.
Rory R KoenenCardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands.
Menno P J de WintherCardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands ; Department of Medical Biochemistry, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
Toby LawrenceCentre d'Immunologie de Marseille-Luminy, Aix-Marseille Université, Marseille, France.
Jürgen BernhagenInstitute of Biochemistry and Molecular Cell Biology, RWTH Aachen University, Aachen, Germany ; August-Lenz-Stiftung, Institute for Cardiovascular Research, Ludwig-Maximilians-University Munich, Munich, Germany.
Alma ZerneckeRudolf Virchow Center and Institute of Clinical Biochemistry and Pathobiochemistry, University of Würzburg, Würzburg, Germany ; Department of Vascular Surgery, Klinikum rechts der Isar Technical University Munich, Munich, Germany ; German Centre for Cardiovascular Research, partner site Munich Heart Alliance, Munich, Germany.
Christian WeberCardiovascular Research Institute Maastricht, Maastricht University, Maastricht, The Netherlands ; Institute for Cardiovascular Prevention, Ludwig-Maximilians-University Munich, Munich, Germany ; German Centre for Cardiovascular Research, partner site Munich Heart Alliance, Munich, Germany.
Heidi NoelsInstitute of Molecular Cardiovascular Research, RWTH Aachen University, Aachen, Germany.
RWTH Aachen University · DELudwig-Maximilians-Universität München · DEAix-Marseille Université · FRMaastricht University · NLAmsterdam UMC Location University of Amsterdam · NLCentre d’Immunologie de Marseille-Luminy · FRKlinikum rechts der Isar · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe Ikkα kinase, a subunit of the NF-κB-activating IKK complex, has emerged as an important regulator of inflammatory gene expression. However, the role of Ikkα-mediated phosphorylation in haematopoiesis and atherogenesis remains unexplored. In this study, we investigated the effect of a bone marrow (BM)-specific activation-resistant Ikkα mutant knock-in on haematopoiesis and atherosclerosis in mice. METHODS AND

resultsApolipoprotein E (Apoe)-deficient mice were transplanted with BM carrying an activation-resistant Ikkα gene (Ikkα(AA/AA)Apoe(-/-) ) or with Ikkα(+/+)Apoe(-/-) BM as control and were fed a high-cholesterol diet for 8 or 13 weeks. Interestingly, haematopoietic profiling by flow cytometry revealed a significant decrease in B-cells, regulatory T-cells and effector memory T-cells in Ikkα(AA/AA)Apoe(-/-) BM-chimeras, whereas the naive T-cell population was increased. Surprisingly, no differences were observed in the size, stage or cellular composition of atherosclerotic lesions in the aorta and aortic root of Ikkα(AA/AA)Apoe(-/-) vs Ikkα(+/+)Apoe(-/-) BM-transplanted mice, as shown by histological and immunofluorescent stainings. Necrotic core sizes, apoptosis, and intracellular lipid deposits in aortic root lesions were unaltered. In vitro, BM-derived macrophages from Ikkα(AA/AA)Apoe(-/-) vs Ikkα(+/+)Apoe(-/-) mice did not show significant differences in the uptake of oxidized low-density lipoproteins (oxLDL), and, with the exception of Il-12, the secretion of inflammatory proteins in conditions of Tnf-α or oxLDL stimulation was not significantly altered. Furthermore, serum levels of inflammatory proteins as measured with a cytokine bead array were comparable.

conclusionOur data reveal an important and previously unrecognized role of haematopoietic Ikkα kinase activation in the homeostasis of B-cells and regulatory T-cells. However, transplantation of Ikkα(AA) mutant BM did not affect atherosclerosis in Apoe(-/-) mice. This suggests that the diverse functions of Ikkα in haematopoietic cells may counterbalance each other or may not be strong enough to influence atherogenesis, and reveals that targeting haematopoietic Ikkα kinase activity alone does not represent a therapeutic approach.

Indexed as

MutationAnimalsApolipoproteins EAtherosclerosisB-LymphocytesBone MarrowBone Marrow CellsBone Marrow TransplantationCells, CulturedFlow CytometryHematopoiesisI-kappa B KinaseInterleukin-12Lipoproteins, LDLMacrophagesMiceApolipoproteins EI-kappa B KinaseInterleukin-12Lipoproteins, LDLoxidized low density lipoproteinTumor Necrosis Factor-alpha

Identifiers

PMID24498325
PMCPMC3911989
OpenAlexW2038508660

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.